179 related articles for article (PubMed ID: 19125798)
21. Dose and volume reduction for normal lung using intensity-modulated radiotherapy for advanced-stage non-small-cell lung cancer.
Murshed H; Liu HH; Liao Z; Barker JL; Wang X; Tucker SL; Chandra A; Guerrero T; Stevens C; Chang JY; Jeter M; Cox JD; Komaki R; Mohan R
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1258-67. PubMed ID: 15001271
[TBL] [Abstract][Full Text] [Related]
22. Intensity-modulated radiation therapy in the treatment of gastric cancer: early clinical outcome and dosimetric comparison with conventional techniques.
Milano MT; Garofalo MC; Chmura SJ; Farrey K; Rash C; Heimann R; Jani AB
Br J Radiol; 2006 Jun; 79(942):497-503. PubMed ID: 16714752
[TBL] [Abstract][Full Text] [Related]
23. 3D conformal radiotherapy for gastric cancer--results of a comparative planning study.
Leong T; Willis D; Joon DL; Condron S; Hui A; Ngan SY
Radiother Oncol; 2005 Mar; 74(3):301-6. PubMed ID: 15763311
[TBL] [Abstract][Full Text] [Related]
24. IMRT for postoperative treatment of gastric cancer: covering large target volumes in the upper abdomen: a comparison of a step-and-shoot and an arc therapy approach.
Wieland P; Dobler B; Mai S; Hermann B; Tiefenbacher U; Steil V; Wenz F; Lohr F
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1236-44. PubMed ID: 15234061
[TBL] [Abstract][Full Text] [Related]
25. Dosimetric definitions of total lung volumes in calculating parameters predictive for radiation-induced pneumonitis.
Kabolizadeh P; Kalash R; Huq MS; Greenberger JS; Heron DE; Beriwal S
Am J Clin Oncol; 2015 Aug; 38(4):401-4. PubMed ID: 24064747
[TBL] [Abstract][Full Text] [Related]
26. Adenocarcinomas of the esophagogastric junction are more likely to respond to preoperative chemotherapy than distal gastric cancer.
Reim D; Gertler R; Novotny A; Becker K; zum Büschenfelde CM; Ebert M; Dobritz M; Langer R; Hoefler H; Friess H; Schumacher C
Ann Surg Oncol; 2012 Jul; 19(7):2108-18. PubMed ID: 22130620
[TBL] [Abstract][Full Text] [Related]
27. Dosimetric evaluation of conventional radiotherapy, 3-D conformal radiotherapy and direct machine parameter optimisation intensity-modulated radiotherapy for breast cancer after conservative surgery.
Zhang F; Zheng M
J Med Imaging Radiat Oncol; 2011 Dec; 55(6):595-602. PubMed ID: 22141607
[TBL] [Abstract][Full Text] [Related]
28. Dosimetric comparison between 2-dimensional radiation therapy and intensity modulated radiation therapy in treatment of advanced T-stage nasopharyngeal carcinoma: to treat less or more in the planning organ-at-risk volume of the brainstem and spinal cord.
Chau RM; Teo PM; Kam MK; Leung SF; Cheung KY; Chan AT
Med Dosim; 2007; 32(4):263-70. PubMed ID: 17980826
[TBL] [Abstract][Full Text] [Related]
29. Comparison of locoregional versus extended locoregional radiation volumes for patients with nonmetastatic gastro-esophageal junction carcinomas.
Wang J; Milton DR; He L; Komaki R; Liao Z; Crane CH; Minsky BD; Thall PF; Lin SH
J Thorac Oncol; 2015 Mar; 10(3):518-26. PubMed ID: 25695222
[TBL] [Abstract][Full Text] [Related]
30. Intraoperative radiotherapy for the treatment of resectable locally advanced gastric adenocarcinoma: topography of locoregional recurrences and long-term outcomes.
Calvo FA; Sole CV; Obregón R; Gómez-Espí M; González-San Segundo C; González-Bayón L; Alvarez E; García-Sabrido JL
Clin Transl Oncol; 2013 Jun; 15(6):443-9. PubMed ID: 23143948
[TBL] [Abstract][Full Text] [Related]
31. Limited advantages of intensity-modulated radiotherapy over 3D conformal radiation therapy in the adjuvant management of gastric cancer.
Alani S; Soyfer V; Strauss N; Schifter D; Corn BW
Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):562-6. PubMed ID: 19427558
[TBL] [Abstract][Full Text] [Related]
32. Intensity-modulated radiotherapy improves target coverage, spinal cord sparing and allows dose escalation in patients with locally advanced cancer of the larynx.
Clark CH; Bidmead AM; Mubata CD; Harrington KJ; Nutting CM
Radiother Oncol; 2004 Feb; 70(2):189-98. PubMed ID: 15028407
[TBL] [Abstract][Full Text] [Related]
33. Results of multifield conformal radiation therapy of nonsmall-cell lung carcinoma using multileaf collimation beams.
Bahri S; Flickinger JC; Kalend AM; Deutsch M; Belani CP; Sciurba FC; Luketich JD; Greenberger JS
Radiat Oncol Investig; 1999; 7(5):297-308. PubMed ID: 10580899
[TBL] [Abstract][Full Text] [Related]
34. [Approaches to individual radiotherapy in breast cancer: individual risk estimation and individualized techniques].
Kahán Z; Varga Z; Csenki M; Szabó J; Szil E; Fekete G; Hideghéty K; Boda K; Thurzó L
Orv Hetil; 2007 May; 148(18):833-41. PubMed ID: 17468066
[TBL] [Abstract][Full Text] [Related]
35. [Dosimetric evaluation of intensity-modulated tangential beam versus conventional tangential irradiation for breast cancer].
Huang XB; Jiang GL; Chen JY; Chen LF; Hu WG
Ai Zheng; 2006 Jul; 25(7):855-60. PubMed ID: 16831277
[TBL] [Abstract][Full Text] [Related]
36. Perioperative chemotherapy for resectable gastroesophageal cancer: a single-center experience.
Molina R; Lamarca A; Martínez-Amores B; Gutiérrez A; Blázquez A; López A; Granell J; Álvarez-Mon M
Eur J Surg Oncol; 2013 Aug; 39(8):814-22. PubMed ID: 23755989
[TBL] [Abstract][Full Text] [Related]
37. Adjuvant chemoradiotherapy with or without intraoperative radiotherapy for the treatment of resectable locally advanced gastric adenocarcinoma.
Zhang Q; Tey J; Peng L; Yang Z; Xiong F; Jiang R; Liu T; Fu S; Lu JJ
Radiother Oncol; 2012 Jan; 102(1):51-5. PubMed ID: 22178689
[TBL] [Abstract][Full Text] [Related]
38. Can all centers plan intensity-modulated radiotherapy (IMRT) effectively? An external audit of dosimetric comparisons between three-dimensional conformal radiotherapy and IMRT for adjuvant chemoradiation for gastric cancer.
Chung HT; Lee B; Park E; Lu JJ; Xia P
Int J Radiat Oncol Biol Phys; 2008 Jul; 71(4):1167-74. PubMed ID: 18234440
[TBL] [Abstract][Full Text] [Related]
39. The rationale and evidence for radiotherapy in the management of gastroesophageal junction tumors.
Haustermans K
Am Soc Clin Oncol Educ Book; 2013; ():. PubMed ID: 23714484
[TBL] [Abstract][Full Text] [Related]
40. [Clinical and pathological prognostic factors for cancers of the esophagogastric junction].
Schmidt SC; Schlechtweg N; Veltzke-Schlieker W; Thuss-Patience P; Pratschke J; Neuhaus P; Schumacher G
Zentralbl Chir; 2009 Sep; 134(5):455-61. PubMed ID: 19757346
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
